SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-00-001761
Filing Date
2000-03-29
Accepted
2000-03-29 00:00:00
Documents
17
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 BIOGEN INC. 10-K 95830
2 1985 NON0QUALIFIED STOCK OPTION PLAN EX-10.27 23751
3 AMENDMENT NO. 3 DATED 9/27/99 EX-10.32 5205
4 AMENDMENT NO. 4 DATED 12/13/99 EX-10.33 3472
5 AMEND. #1 TO AMENDED & RESTATED SUPPLEMENTAL EX-10.35 1321
6 AMENDMENT NO. 3 DATED 9/27/99 EX-10.39 3869
7 AMENDMENT NO. 4 TO VOLUNTARY BOARD PLAN EX-10.40 1557
8 LETTER AGREEMENT WITH JAMES VINCENT EX-10.50 3199
9 LETTER REGARDING EMPLOYMENT OF JAMES MULLEN EX-10.51 2504
10 LETTER AMENDING AGREEMENT DATED 1/7/99 EX-10.52 1039
11 LETTER REGARDING EMPLOYMENT OF BURT ADELMAN EX-10.53 3119
12 LETTER REGARDING EMPLOYMENT OF MARK LEUCHTENBERGER EX-10.54 3543
13 LETTER AMENDING AGREEMENT DATED MAY 12, 1999 EX-10.55 12075
14 PORTIONS OF FINANCIAL STATEMENTS EX-13 168470
15 SUBSIDIARIES EX-21 1741
16 CONSENT OF PRICEWATERHOUSECOOPERS EX-23 837
17 FINANCIAL DATA SCHEDULE EX-27 2440
  Complete submission text file 0000950135-00-001761.txt   337274
Mailing Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 6176792000
BIOGEN INC (Filer) CIK: 0000714655 (see all company filings)

IRS No.: 043002117 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12042 | Film No.: 583096
SIC: 2836 Biological Products, (No Diagnostic Substances)